Richard J. Lewis
Corporate Officer/Principal at The University of Queensland
Richard J. Lewis active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The University of Queensland | Corporate Officer/Principal | 2009-06-30 | - |
| National Health & Medical Research Council | Corporate Officer/Principal | 2009-06-30 | - |
Career history of Richard J. Lewis
Former positions of Richard J. Lewis
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Corporate Officer/Principal | 2009-06-30 | - |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Chief Tech/Sci/R&D Officer | 1999-12-31 | - |
| Founder | 2010-02-07 | - |
Statistics
International
| Australia | 4 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
| Private companies | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
| National Health & Medical Research Council | Government |
- Stock Market
- Insiders
- Richard J. Lewis
- Experience
